The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma.
 
Haifeng Lin
No Relationships to Disclose
 
Jie Ma
No Relationships to Disclose
 
Manyun Zhuo
No Relationships to Disclose
 
Chengsheng Zhang
No Relationships to Disclose
 
Jingru Luo
No Relationships to Disclose
 
Xiaohong Zhuang
No Relationships to Disclose
 
Zhiming Zeng
No Relationships to Disclose
 
Lihua Yang
No Relationships to Disclose